• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体钾通道 TMEM175 促进细胞凋亡,加重帕金森病症状。

Lysosomal K channel TMEM175 promotes apoptosis and aggravates symptoms of Parkinson's disease.

机构信息

Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Neurodegenerative Disorder Research Center, University of Science and Technology of China, Hefei, China.

出版信息

EMBO Rep. 2022 Sep 5;23(9):e53234. doi: 10.15252/embr.202153234. Epub 2022 Aug 1.

DOI:10.15252/embr.202153234
PMID:35913019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9442313/
Abstract

Lysosomes are degradative organelles and play vital roles in a variety of cellular processes. Ion channels on the lysosomal membrane are key regulators of lysosomal function. TMEM175 has been identified as a lysosomal potassium channel, but its modulation and physiological functions remain unclear. Here, we show that the apoptotic regulator Bcl-2 binds to and inhibits TMEM175 activity. Accordingly, Bcl-2 inhibitors activate the channel in a caspase-independent way. Increased TMEM175 function inhibits mitophagy, disrupts mitochondrial homeostasis, and increases production of reactive oxygen species (ROS). ROS further activates TMEM175 and thus forms a positive feedback loop to augment apoptosis. In a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease (PD), knockout (KO) of TMEM175 mitigated motor impairment and dopaminergic (DA) neuron loss, suggesting that TMEM175-mediated apoptosis plays an important role in Parkinson's disease (PD). Overall, our study reveals that TMEM175 is an important regulatory site in the apoptotic signaling pathway and a potential therapeutic target for Parkinson's disease (PD).

摘要

溶酶体是一种降解性细胞器,在多种细胞过程中发挥着重要作用。溶酶体膜上的离子通道是溶酶体功能的关键调节剂。TMEM175 已被鉴定为溶酶体钾通道,但它的调节和生理功能仍不清楚。在这里,我们发现凋亡调节剂 Bcl-2 与 TMEM175 结合并抑制其活性。相应地,Bcl-2 抑制剂以 caspase 非依赖性方式激活该通道。TMEM175 功能的增加抑制了线粒体自噬,破坏了线粒体的动态平衡,并增加了活性氧物质 (ROS) 的产生。ROS 进一步激活 TMEM175,从而形成正反馈环以增强细胞凋亡。在帕金森病 (PD) 的 1-甲基-4-苯基-1,2,3,6-四氢吡啶 (MPTP) 小鼠模型中,TMEM175 的敲除 (KO) 减轻了运动障碍和多巴胺能 (DA) 神经元的丧失,表明 TMEM175 介导线粒体凋亡在帕金森病 (PD) 中发挥着重要作用。总的来说,我们的研究揭示了 TMEM175 是细胞凋亡信号通路中的一个重要调节位点,也是帕金森病 (PD) 的一个潜在治疗靶点。

相似文献

1
Lysosomal K channel TMEM175 promotes apoptosis and aggravates symptoms of Parkinson's disease.溶酶体钾通道 TMEM175 促进细胞凋亡,加重帕金森病症状。
EMBO Rep. 2022 Sep 5;23(9):e53234. doi: 10.15252/embr.202153234. Epub 2022 Aug 1.
2
A growth-factor-activated lysosomal K channel regulates Parkinson's pathology.生长因子激活的溶酶体钾通道调节帕金森病病理。
Nature. 2021 Mar;591(7850):431-437. doi: 10.1038/s41586-021-03185-z. Epub 2021 Jan 27.
3
Transmembrane Protein 175, a Lysosomal Ion Channel Related to Parkinson's Disease.跨膜蛋白 175,一种与帕金森病相关的溶酶体离子通道。
Biomolecules. 2023 May 9;13(5):802. doi: 10.3390/biom13050802.
4
Mechanism and therapeutic targets of the involvement of a novel lysosomal proton channel TMEM175 in Parkinson's disease.新型溶酶体质子通道 TMEM175 参与帕金森病的机制及治疗靶点。
Ageing Res Rev. 2024 Sep;100:102373. doi: 10.1016/j.arr.2024.102373. Epub 2024 Jul 2.
5
TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.跨膜蛋白175(TMEM175)缺陷会损害溶酶体和线粒体功能,并增加α-突触核蛋白的聚集。
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2389-2394. doi: 10.1073/pnas.1616332114. Epub 2017 Feb 13.
6
Discovery of Selective Inhibitors for the Lysosomal Parkinson's Disease Channel TMEM175.发现溶酶体帕金森病通道 TMEM175 的选择性抑制剂。
J Am Chem Soc. 2024 Aug 21;146(33):23230-23239. doi: 10.1021/jacs.4c05623. Epub 2024 Aug 8.
7
Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel.溶酶体 LAMP 蛋白通过直接抑制 TMEM175 通道来调节溶酶体 pH。
Mol Cell. 2023 Jul 20;83(14):2524-2539.e7. doi: 10.1016/j.molcel.2023.06.004. Epub 2023 Jun 29.
8
Common and Rare Variants in TMEM175 Gene Concur to the Pathogenesis of Parkinson's Disease in Italian Patients.TMEM175 基因的常见和罕见变异共同导致意大利患者帕金森病的发病机制。
Mol Neurobiol. 2023 Apr;60(4):2150-2173. doi: 10.1007/s12035-022-03203-9. Epub 2023 Jan 7.
9
Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes.帕金森病风险蛋白 TMEM175 是溶酶体中的一种质子激活质子通道。
Cell. 2022 Jun 23;185(13):2292-2308.e20. doi: 10.1016/j.cell.2022.05.021.
10
Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.青蒿叶提取物通过激活 TRPML1 并促进自噬/线粒体自噬清除,在 MPP+/MPTP 诱导的帕金森病的体外和体内模型中发挥保护神经元毒性的作用。
Phytomedicine. 2022 Sep;104:154250. doi: 10.1016/j.phymed.2022.154250. Epub 2022 Jun 15.

引用本文的文献

1
Glutamate-cysteine ligase as a diagnostic biomarker and therapeutic target in Parkinson's disease: a multi-omics and experimental study.谷氨酸-半胱氨酸连接酶作为帕金森病的诊断生物标志物和治疗靶点:一项多组学与实验研究
Eur J Med Res. 2025 Aug 6;30(1):721. doi: 10.1186/s40001-025-02921-9.
2
The Link Between Endoplasmic Reticulum Stress and Lysosomal Dysfunction Under Oxidative Stress in Cancer Cells.癌细胞氧化应激下内质网应激与溶酶体功能障碍之间的联系
Biomolecules. 2025 Jun 25;15(7):930. doi: 10.3390/biom15070930.
3
Lysosomal ion channels and pain.溶酶体离子通道与疼痛。
Pain Rep. 2025 Jun 5;10(4):e1282. doi: 10.1097/PR9.0000000000001282. eCollection 2025 Aug.
4
TMEM175 activity in BK-deficient macrophages maintains lysosomal function and mediates silica-induced inflammatory response in macrophages.BK 缺陷型巨噬细胞中的 TMEM175 活性维持溶酶体功能并介导巨噬细胞中二氧化硅诱导的炎症反应。
Inhal Toxicol. 2025 Apr;37(4):173-182. doi: 10.1080/08958378.2025.2507251. Epub 2025 May 22.
5
HucMSCs-derived Exosomes Protect Against 6-hydroxydopamineinduced Parkinson's Disease in Rats by Inhibiting Caspase-3 Expression and Suppressing Apoptosis.人脐带间充质干细胞来源的外泌体通过抑制半胱天冬酶-3表达和抑制细胞凋亡来预防6-羟基多巴胺诱导的大鼠帕金森病。
Curr Stem Cell Res Ther. 2025;20(3):266-278. doi: 10.2174/011574888X301827240613063513.
6
Lysosomal Ion Channels and Transporters: Recent Findings, Therapeutic Potential, and Technical Approaches.溶酶体离子通道与转运体:最新发现、治疗潜力及技术方法
Bioelectricity. 2025 Mar 18;7(1):29-57. doi: 10.1089/bioe.2025.0010. eCollection 2025 Mar.
7
Identification of inverted U-shaped curve association between serum potassium and prodromal Parkinson's disease.血清钾与前驱帕金森病之间倒U形曲线关联的识别。
Clin Park Relat Disord. 2025 Apr 9;12:100323. doi: 10.1016/j.prdoa.2025.100323. eCollection 2025.
8
Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia.帕金森病与路易体痴呆之间常见脑蛋白及基因位点的鉴定
CNS Neurosci Ther. 2025 Apr;31(4):e70370. doi: 10.1111/cns.70370.
9
Fibrinogen degradation products exacerbate alpha-synuclein aggregation by inhibiting autophagy via downregulation of Beclin1 in multiple system atrophy.纤维蛋白原降解产物通过下调多系统萎缩中Beclin1抑制自噬,从而加剧α-突触核蛋白聚集。
Neurotherapeutics. 2025 Mar;22(2):e00538. doi: 10.1016/j.neurot.2025.e00538. Epub 2025 Feb 4.
10
Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease.解析TMEM175的pH调节机制,一种在内溶酶体阳离子通道中发挥作用且与帕金森病相关的蛋白
J Cell Physiol. 2025 Feb;240(2):e70008. doi: 10.1002/jcp.70008.

本文引用的文献

1
A growth-factor-activated lysosomal K channel regulates Parkinson's pathology.生长因子激活的溶酶体钾通道调节帕金森病病理。
Nature. 2021 Mar;591(7850):431-437. doi: 10.1038/s41586-021-03185-z. Epub 2021 Jan 27.
2
Mitochondria-lysosome contacts regulate mitochondrial Ca dynamics via lysosomal TRPML1.线粒体-溶酶体接触通过溶酶体 TRPML1 调节线粒体 Ca 动力学。
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19266-19275. doi: 10.1073/pnas.2003236117. Epub 2020 Jul 23.
3
Gating and selectivity mechanisms for the lysosomal K channel TMEM175.溶酶体 K 通道 TMEM175 的门控和选择性机制。
Elife. 2020 Mar 31;9:e53430. doi: 10.7554/eLife.53430.
4
Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease.TMEM175 p.M393T 变异体的功能化是帕金森病的风险因素。
Hum Mol Genet. 2019 Oct 1;28(19):3244-3254. doi: 10.1093/hmg/ddz136.
5
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.BCL-2 与 venetoclax 复合物的结构揭示了耐药突变的分子基础。
Nat Commun. 2019 Jun 3;10(1):2385. doi: 10.1038/s41467-019-10363-1.
6
Regulation and Function of Mitochondria-Lysosome Membrane Contact Sites in Cellular Homeostasis.线粒体-溶酶体膜接触位点在细胞稳态中的调节和功能。
Trends Cell Biol. 2019 Jun;29(6):500-513. doi: 10.1016/j.tcb.2019.02.004. Epub 2019 Mar 18.
7
The lysosome as a cellular centre for signalling, metabolism and quality control.溶酶体作为细胞信号转导、代谢和质量控制的中心。
Nat Cell Biol. 2019 Feb;21(2):133-142. doi: 10.1038/s41556-018-0244-7. Epub 2019 Jan 2.
8
Balancing Apoptosis and Autophagy for Parkinson's Disease Therapy: Targeting BCL-2.平衡细胞凋亡和自噬治疗帕金森病:靶向 BCL-2。
ACS Chem Neurosci. 2019 Feb 20;10(2):792-802. doi: 10.1021/acschemneuro.8b00356. Epub 2019 Feb 11.
9
Lysosomal storage diseases.溶酶体贮积症。
Nat Rev Dis Primers. 2018 Oct 1;4(1):27. doi: 10.1038/s41572-018-0025-4.
10
Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration.线粒体、溶酶体和功能障碍:它们在神经退行性变中的意义。
J Neurochem. 2018 Nov;147(3):291-309. doi: 10.1111/jnc.14471. Epub 2018 Aug 2.